63 results
Keyword pulmonology Remove keyword
-
List item
National expert: Michal Pirozynski, Medicines Authority (updated)
- Declaration of interests - 79.94 KB | PDF
- Curriculum Vitae - 17.94 KB | PDF
certified CMKP (Poland) pulmonology November 1997- board certified CMKP … Education, Head of Allergy, Pulmonology, Emergency; Maltese Medicines … -
List item
National expert: Hugues Malonne, Federal Agency for Medicines and Health Products (updated)
- Declaration of interests - 81.15 KB | PDF
- Curriculum Vitae - 35.23 KB | PDF
Medrol Various diseases in pulmonology 09/2016-12/2016 Sanofi … -
List item
National expert: Doina Plesca, European Medicines Agency (updated)
- Declaration of interests - 82.41 KB | PDF
- Curriculum Vitae - 19.95 KB | PDF
neurology, specialisation in Paediatric Pulmonology Facultaty of Medicine , University … INFORMATION Expertise Primary Paediatric pulmonology Primary Paediatric neurology Primary … of the European Society of Pulmonology (ERS) Member of the International … -
List item
National expert: Jessica Harskamp, Medicines Evaluation Board (updated)
- Declaration of interests - 79.8 KB | PDF
- Curriculum Vitae - 16.32 KB | PDF
Netherlands) Focus on hemato-oncology and pulmonology. EDUCATION AND TRAINING September … Hemato-oncology; immunology; pulmonology; geriatrics. Publications Projects Memberships Other … -
List item
National expert: Miranda Vroenhove, Federal Agency for Medicines and Health Products (updated)
- Declaration of interests - 79.8 KB | PDF
- Curriculum Vitae - 16.95 KB | PDF
assessment of medicines in the pulmonology/respiratory and endocrinology domain … -
List item
National expert: Marek Migdal, The Office for Registration of Medicinal Products, Medical Devices and Biocides (updated)
- Declaration of interests - 84.54 KB | PDF
- Curriculum Vitae - 18.29 KB | PDF
TRAINING - MD, PhD - paediatric pulmonologist () 1985- 1986 Researcher … intensive care, paediatric pulmonology, clinical trials in paediatric … -
List item
National expert: Tim Lee, European Medicines Agency (updated)
- Declaration of interests - 81.84 KB | PDF
- Curriculum Vitae - 23.57 KB | PDF
of Bronchology and Interventional Pulmonology 2011; 18: 57-60 Barton … fibrosis centre. Pediatric Pulmonology 2004; 37: 104-110. Lee TWR … -
List item
National expert: Ole Henrik Myrdal, Norwegian Medicines Agency (updated)
- Declaration of interests - 79.78 KB | PDF
- Curriculum Vitae - 16.89 KB | PDF
2012-August 2021 Medical doctor, pulmonologist Department of Respiratory … Norway) August 2006-April 2016 Pulmonologist the Norwegian Directorate … -
List item
National expert: Janet Koenig, Federal Institute for Drugs and Medical Devices (updated)
- Declaration of interests - 79.85 KB | PDF
- Curriculum Vitae - 17.74 KB | PDF
Anaesthesiology Algesiology Pulmonology Publications 1. Schriever … -
List item
National expert: Vesa Kiviniemi, Finnish Medicines Agency (updated)
- Declaration of interests - 79.89 KB | PDF
- Curriculum Vitae - 22.63 KB | PDF
Later Asthma. Pediatric Pulmonology, 2009, 45(4), 406-408. 20. Jantti … -
List item
National expert: Patrick Vrijlandt, Medicines Evaluation Board (updated)
- Declaration of interests - 79.97 KB | PDF
- Curriculum Vitae - 20.89 KB | PDF
intensive care, cardiology, pulmonology) 07/03/2022 Page 1/3European … -
List item
National expert: Robertas Lazauskas, Lithuania States Medicines Control Agency (updated)
- Declaration of interests - 79.81 KB | PDF
- Curriculum Vitae - 22.51 KB | PDF
-
List item
National expert: Christine Siezen, Medicines Evaluation Board (updated)
- Declaration of interests - 80.06 KB | PDF
- Curriculum Vitae - 21.68 KB | PDF
gender-specific effect. Pediatric pulmonology, 45:608-13, 2010. van den … -
List item
Human medicine European public assessment report (EPAR): Xolair (updated)
omalizumab, Asthma; Urticaria
Date of authorisation: 25/10/2005, Revision: 44, Authorised, Last updated: 01/02/2023 -
List item
Human medicine European public assessment report (EPAR): Kaftrio (updated)
ivacaftor, tezacaftor, elexacaftor, Cystic Fibrosis
Date of authorisation: 21/08/2020,
, 
, Revision: 11, Authorised, Last updated: 16/01/2023
-
List item
National expert: Gunther Boos, Federal Institute for Drugs and Medical Devices (updated)
- Declaration of interests - 79.8 KB | PDF
- Curriculum Vitae - 16.91 KB | PDF
algesiology, rheumatology, pulmonology and otorhinolaryngology September … -
List item
Human medicine European public assessment report (EPAR): Sialanar
glycopyrronium bromide, Sialorrhea
Date of authorisation: 15/09/2016, Revision: 9, Authorised, Last updated: 15/09/2022 -
List item
Human medicine European public assessment report (EPAR): Symkevi
tezacaftor, ivacaftor, Cystic Fibrosis
Date of authorisation: 31/10/2018,, , Revision: 10, Authorised, Last updated: 07/06/2022
-
List item
National expert: Robin Vos, European Medicines Agency (updated)
- Declaration of interests - 82.45 KB | PDF
- Curriculum Vitae - 25.42 KB | PDF
-
List item
Human medicine European public assessment report (EPAR): Hukyndra (updated)
adalimumab, Arthritis, Psoriatic; Arthritis, Juvenile Rheumatoid; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Hidradenitis Suppurativa; Psoriasis; Spondylitis, Ankylosing; Uveitis
Date of authorisation: 15/11/2021,
, Revision: 3, Authorised, Last updated: 16/01/2023
-
List item
Human medicine European public assessment report (EPAR): Enhertu
trastuzumab deruxtecan, Breast Neoplasms
Date of authorisation: 18/01/2021,, 
, Revision: 9, Authorised, Last updated: 17/11/2022
-
List item
Human medicine European public assessment report (EPAR): Libmyris (updated)
adalimumab, Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic; Psoriasis; Hidradenitis Suppurativa; Crohn Disease; Colitis, Ulcerative; Uveitis
Date of authorisation: 12/11/2021,, Revision: 1, Authorised, Last updated: 11/01/2023
-
List item
Human medicine European public assessment report (EPAR): Kalydeco
ivacaftor, Cystic Fibrosis
Date of authorisation: 23/07/2012,
, Revision: 34, Authorised, Last updated: 21/10/2022
-
List item
Human medicine European public assessment report (EPAR): Tobi Podhaler
Tobramycin, Cystic Fibrosis; Respiratory Tract Infections
Date of authorisation: 20/07/2011,, Revision: 19, Authorised, Last updated: 13/05/2022
-
List item
National expert: Karoline Buhre, Federal Institute for Drugs and Medical Devices (updated)
- Declaration of interests - 79.89 KB | PDF
- Curriculum Vitae - 18.84 KB | PDF